Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy

This literature review summarizes all current clinical and scientific knowledge for a new cancer treatment called neoadjuvant immune checkpoint blockade. This is important because literature reviews form the knowledge base of new research studies and highlight the gaps that lead to new research questions and experiments in lung cancer. Senior author Kellie N. Smith received honors by the Pierre Massion Lung Cancer Discovery Award.